Knowledge, experience and skill are Ingredients in Everything We Make
Our Management Team
The WellSpring management team is passionate about one thing: providing pharmaceutical contract formulation development, manufacturing and packaging services that will help you realize your product’s full potential. They bring experience in pharmaceutical manufacturing, packaging, quality assurance and quality control testing from some of the world’s largest CDMOs/CMOs and pharmaceutical companies. Committed to quality and customer service, they work continually to build on WellSpring's culture of integrity, trust and reliability.
executive director, operations & product development services
Mr. David Watt brings over 25 years of outstanding technical and operational expertise in the designing, manufacturing and evaluating of key pharmaceutical products for commercial markets. He has led solid dose, liquid, and semi-solid contract development and manufacturing projects both from the pharmaceutical and contract manufacturer (CDMO) perspectives at leading multinational companies. He currently serves as the Executive Director, Operations & Product Development for ANI Pharmaceuticals, formerly Wellspring Pharma Services. Prior to joining WellSpring, David worked at prominent companies including Valeant, Medicis, Patheon, and Syntex Pharmaceuticals. In his role as Executive Director, David oversees operations and process development support and provides technical project management for technology transfer projects and process improvements. David has a Double Honours Specialist in Microbiology/Biochemistry from the University of Toronto.
Dara Caratao, PMP
Director, Program Management
Dara Caratao has been with WellSpring Pharma Services since 2008 and brings over 15 years of pharmaceutical project management experience for contract development and manufacturing projects. She worked at Patheon prior to joining Wellspring. In her role as director of program management, Dara directs planning and implementation of technology transfer projects.
Share the Risks and Rewards, Talk to WellSpring
Not every CMO has the flexibility that small and virtual biopharmaceutical companies need to move their product through clinical trials and into commercial production. If you have a product requiring esoteric equipment or a novel manufacturing process, you should know WellSpring has significant experience negotiating cost-sharing contracts with clients in order to acquire the equipment needed to facilitate production on any product type or form.